Mersana Therapeutics Inc (NAS:MRSN)
$ 2.37 0.07 (3.04%) Market Cap: 292.77 Mil Enterprise Value: 160.46 Mil PE Ratio: 0 PB Ratio: 237.00 GF Score: 29/100

Q1 2021 Mersana Therapeutics Inc Earnings Call Transcript

May 10, 2021 / 08:30PM GMT
Release Date Price: $14.92 (-3.24%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Mersana's First Quarter 2021 Earnings Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker host, Sarah Carmody. Go ahead.

Sarah Carmody
Mersana Therapeutics, Inc. - Executive Director of IR & Corporate Communications

Good afternoon. Welcome to Mersana's first quarter 2021 conference call. Earlier today, we issued a press release reviewing our first quarter financial results and business updates, which will be covered on this call. A replay of today's call will be available on the Investors and Media section of our website. After our prepared remarks, we will open the call for Q&A.

Before we begin, I'd like to mention that our call will contain forward-looking statements within the meaning of the federal securities laws. These are not statements of historical facts and are based on management's beliefs and assumptions and on information currently available. They are subject to risks and uncertainties that could cause the actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot